Tuesday, October 20, 2026, 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
April 2021—Test volumes and positivity rates were down and vaccinations and interest in variants were up on March 2 when Compass Group laboratory leaders met with CAP TODAY publisher Bob McGonnagle for another in a series of calls about SARS-CoV-2. Also in the discussion: antigen and serologic testing, school and sports team testing, and testing for travel.
Gene Herbek, MD, FCAP, was a respected pathologist at Methodist Hospital for nearly 20 years as well as a beloved husband, father, and friend. His passing in 2020 was a tremendous loss for his loved ones, patients, and colleagues.
The Women’s Methodist Hospital pathology department, Methodist Hospital, and the CAP Foundation together with Dr. Herbek’s family present the Herbek Hustle 5K Memorial Fun Run on June 19.
mTuitive, a software company that develops data capture and synoptic reporting software to assist health care professionals, released a case study, “Provincial Laboratory Medicine Services Unifies Synoptic Pathology Reporting Across Province, Creates Central Data Repository for Reporting using mTuitive.” The study details how Provincial Laboratory Medicine Services of British Columbia chose and deployed mTuitive xPert For Pathology. Read the case report here.
BC Solutions explains why third-party blood bank validations might be right for your laboratory in this Q&A. Congratulations! Your lab is finally installing or upgrading your new blood establishment computer system (BECS). Read more.
Dark Daily has published How to Develop a COVID-19 Employee Testing Program: Essential Guidance on Legal, Risk Management, Regulatory, and Compliance Issues for Clinical Laboratories and Employers. For more information and to download the report, click here.
Luminex has published a white paper on COVID-19 testing, authored by distinguished experts in laboratories. Click the link to read and download the paper.
June 2020—Over the last century, the American manufacturing industry has come to appreciate that it is possible to construct a production system that can maximize profits without sacrificing quality. Many industrial pioneers have contributed to this production system, known as the “lean production system,” but it is the Toyota Motor Corporation that is credited with developing it to maturity.
Now out is the Survival Guide to Endocrine Pathology (IP Press), by Sylvia L. Asa, MD, PhD. CAP TODAY talked with Dr. Asa about the new book. What she told us follows.
NorthShore conducting in-house COVID-19 testing
Crain’s Chicago Business reported on March 16 that NorthShore University HealthSystem has started in-house testing for COVID-19. Read the Crain’s article.
The 2019 edition of the CAP accreditation checklists are now available. Some highlights of this edition’s changes include the addition of a new checklist requirement in the chemistry checklist on opiate testing, and the addition of a new checklist requirement in the transfusion medicine checklist to align with the FDA on the labeling of red blood cells with historical antigen typing.
